BlackRock Amends iRhythm Stake, Maintains Significant Position
Ticker: IRTC · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1388658
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, medical-devices
TL;DR
**BlackRock still owns a big chunk of iRhythm, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership in iRhythm Technologies, Inc. as of December 31, 2023. This filing, Amendment No. 6, indicates BlackRock's continued significant institutional holding in the medical device company. For investors, this matters because BlackRock is a major institutional investor, and its sustained position suggests confidence in iRhythm Technologies' long-term prospects, potentially signaling stability to other shareholders.
Why It Matters
This filing shows that a major institutional investor, BlackRock, continues to hold a substantial stake in iRhythm Technologies, which can be seen as a vote of confidence in the company's future.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate negative risks for the company.
Analyst Insight
Investors should note BlackRock's continued presence as a significant shareholder, which may provide a baseline level of institutional confidence in iRhythm Technologies, Inc. However, this filing alone doesn't provide details on changes in share count, so further analysis of BlackRock's specific holdings would be needed for a more complete picture.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- iRhythm Technologies, Inc. (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the date the SC 13G/A was filed
Forward-Looking Statements
- BlackRock will maintain a significant, long-term stake in iRhythm Technologies, Inc. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, specifically Amendment No. 6, filed under Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., a major institutional investment manager.
Which company's shares are the subject of this filing?
The shares that are the subject of this filing belong to iRhythm Technologies, Inc., a company in the surgical and medical instruments & apparatus industry.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, indicating the reporting period for the ownership stake.
What is the CUSIP Number for iRhythm Technologies, Inc. Common Stock?
The CUSIP Number for iRhythm Technologies, Inc. Common Stock is 450056106.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding iRhythm Technologies, Inc. (IRTC).